Safety and pharmacokinetics of FCN-437c, a novel cyclin-dependent kinase 4/6 inhibitor, in Chinese patients with hepatic impairment.

fovinaciclib (FCN-437) - Fosun Pharma

http://www.ncbi.nlm.nih.gov/pubmed/40663244

Jia Xu; Jingrui Liu; Xiaoran Yang; Yanhua Ding; Yi Sun; Yunjie Fu

Jul 15, 2025